Predictive factors for indeterminate result on the QuantiFERON test in an intermediate tuberculosis-burden country

Journal of Infection

Volumn 62, Issue 5, 2011, Pages 347-354

  Jeong, Su Jin ^a   Han, Sang Hoon ^a   Kim, Chang Oh ^a   Baek, Ji hyeon ^a   Jin, Sung Joon ^a   Ku, Nam Su ^a   Choi, Jun Yong ^a   Song, Young Goo ^a   Kim, Hyon Suk ^a   Kim, June Myung ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Indeterminate results; Interferon gamma release assays; Predictive factors; QuantiFERON TB Gold In Tube test

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; STEROID;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CASE CONTROL STUDY; CHRONIC KIDNEY DISEASE; CHRONIC LUNG DISEASE; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; HUMAN; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; QUANTIFERON TUBERCULOSIS GOLD IN TUBE TEST; SOUTH KOREA; TUBERCULOSIS;

ADULT; AGED; CASE-CONTROL STUDIES; CLINICAL LABORATORY TECHNIQUES; FEMALE; HUMANS; IMMUNOASSAY; IMMUNOCOMPROMISED HOST; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; REAGENT KITS, DIAGNOSTIC; REPUBLIC OF KOREA; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

EID: 79956146928     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2011.03.004     Document Type: Article

References (40)

1. Global tuberculosis control: key findings from the December 2009 WHO report. Wkly Epidemiol Rec 2010, 85(9):69-80.
2. Bloom B.R., Murray C.J. Tuberculosis: commentary on a reemergent killer. Science 1992, 257(5073):1055-1064.
3. Tuberculosis elimination revisited: obstacles, opportunities, and a renewed commitment. Advisory Council for the Elimination of Tuberculosis (ACET). MMWR Recomm Rep 1999, 48(RR-9):1-13.
4. Horsburgh C.R. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med 2004, 350(20):2060-2067.
5. Huebner R.E., Schein M.F., Bass J.B. The tuberculin skin test. Clin Infect Dis 1993, 17(6):968-975.
6. Andersen P., Munk M.E., Pollock J.M., Doherty T.M. Specific immune-based diagnosis of tuberculosis. Lancet 2000, 356(9235):1099-1104.
7. Mazurek G.H., Jereb J., Lobue P., Iademarco M.F., Metchock B., Vernon A. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005, 54(RR-15):49-55.
8. Richeldi L. An update on the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 2006, 174(7):736-742.
9. Dogra S., Narang P., Mendiratta D.K., Chaturvedi P., Reingold A.L., Colford J.M., et al. Comparison of a whole blood interferon-gamma assay with tuberculin skin testing for the detection of tuberculosis infection in hospitalized children in rural India. J Infect 2007, 54(3):267-276.
10. Ferrara G., Losi M., Meacci M., Meccugni B., Piro R., Roversi P., et al. Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 2005, 172(5):631-635.
11. Ferrara G., Losi M., D'Amico R., Roversi P., Piro R., Meacci M., et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 2006, 367(9519):1328-1334.
12. Connell T.G., Curtis N., Ranganathan S.C., Buttery J.P. Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children. Thorax 2006, 61(7):616-620.
13. Mahomed H., Hughes E.J., Hawkridge T., Minnies D., Simon E., Little F., et al. Comparison of mantoux skin test with three generations of a whole blood IFN-gamma assay for tuberculosis infection. Int J Tuberc Lung Dis 2006, 10(3):310-316.
14. Nakaoka H., Lawson L., Squire S.B., Coulter B., Ravn P., Brock I., et al. Risk for tuberculosis among children. Emerg Infect Dis 2006, 12(9):1383-1388.
15. WHO. World Health Organization. Tuberculosis. available at: http://www.who.int/tb/country/data/profiles/en/.
16. Mazurek M., Jereb J., Vernon A., LoBue P., Goldberg S., Castro K. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep 2010, 59(RR-5):1-25.
17. NCI. National Cancer Institute. CTEP: NCI Guidance on CTC Terminology Applications. Version 3.0. available at: http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm.
18. Center for Disease Control and Prevention. The difference between latent TB infection and active TB disease. available at: http://www.cdc.gov/tb/publications/factsheets/general/LTBIandActiveTB.htm.
19. International statistical Classification of diseases and Related Health Problem, 10th Revision. Current version 2007, WHO. World Health Organization, available at:. http://www.who.int/classifications/icd/en/index.html.
20. Lee J.Y., Choi H.J., Park I.N., Hong S.B., Oh Y.M., Lim C.M., et al. Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection. Eur Respir J 2006, 28(1):24-30.
21. Meier T., Eulenbruch H.P., Wrighton-Smith P., Enders G., Regnath T. Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice. Eur J Clin Microbiol Infect Dis 2005, 24(8):529-536.
22. Piana F., Codecasa L.R., Cavallerio P., Ferrarese M., Migliori G.B., Barbarano L., et al. Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients. Eur Respir J 2006, 28(1):31-34.
23. Beffa P., Zellweger A., Janssens J.P., Wrighton-Smith P., Zellweger J.P. Indeterminate test results of T-SPOT.TB performed under routine field conditions. Eur Respir J 2008, 31(4):842-846.
24. Chia S., Karim M., Elwood R.K., FitzGerald J.M. Risk of tuberculosis in dialysis patients: a population-based study. Int J Tuberc Lung Dis 1998, 2(12):989-991.
25. Andrew O.T., Schoenfeld P.Y., Hopewell P.C., Humphreys M.H. Tuberculosis in patients with end-stage renal disease. Am J Med 1980, 68(1):59-65.
26. Hussein M., Mooij J.M., Roujouleh H. Tuberculosis and chronic renal disease. Semin Dial 2003, 16(1):38-44.
27. Descamps-Latscha B., Chatenoud L. T cells and B cells in chronic renal failure. Semin Nephrol 1996, 16(3):183-191.
28. Smirnoff M., Patt C., Seckler B., Adler J.J. Tuberculin and anergy skin testing of patients receiving long-term hemodialysis. Chest 1998, 113(1):25-27.
29. Girndt M., Sester U., Sester M., Kaul H., Khler H. Impaired cellular immune function in patients with end-stage renal failure. Nephrol Dial Transplant 1999, 14(12):2807-2810.
30. Chan T.Y. Vitamin D deficiency and susceptibility to tuberculosis. Calcif Tissue Int 2000, 66(6):476-478.
31. Tzanno-Martins C., Futata E., Jorgetti V., Duarte A.J. Restoration of impaired T-cell proliferation after parathyroidectomy in hemodialysis patients. Nephron 2000, 84(3):224-227.
32. Barnes P.J., Shapiro S.D., Pauwels R.A. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 2003, 22(4):672-688.
33. Majo J., Ghezzo H., Cosio M.G. Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur Respir J 2001, 17(5):946-953.
34. Retamales I., Elliott W.M., Meshi B., Coxson H.O., Pare P.D., Sciurba F.C., et al. Amplification of inflammation in emphysema and its association with latent adenoviral infection. Am J Respir Crit Care Med 2001, 164(3):469-473.
35. Sullivan A.K., Simonian P.L., Falta M.T., Mitchell J.D., Cosgrove G.P., Brown K., et al. Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema. Am J Respir Crit Care Med 2005, 172(5):590-596.
36. Di Stefano A., Caramori G., Capelli A., Gnemmi I., Ricciardolo F.L., Oates T., et al. STAT4 activation in smokers and patients with chronic obstructive pulmonary disease. Eur Respir J 2004, 24(1):78-85.
37. Barcel B., Pons J., Fuster A., Sauleda J., Noguera A., Ferrer J.M., et al. Intracellular cytokine profile of T lymphocytes in patients with chronic obstructive pulmonary disease. Clin Exp Immunol 2006, 145(3):474-479.
38. Majori M., Corradi M., Caminati A., Cacciani G., Bertacco S., Pesci A. Predominant TH1 cytokine pattern in peripheral blood from subjects with chronic obstructive pulmonary disease. J Allergy Clin Immunol 1999, 103(3):458-462.
39. Zhu X., Gadgil A.S., Givelber R., George M.P., Stoner M.W., Sciurba F.C., et al. Peripheral T cell functions correlate with the severity of chronic obstructive pulmonary disease. J Immunol 2009, 182(5):3270-3277.
40. Koch A., Gaczkowski M., Sturton G., Staib P., Schinkthe T., Klein E., et al. Modification of surface antigens in blood CD8+ T-lymphocytes in COPD: effects of smoking. Eur Respir J 2007, 29(1):42-50.